The purpose of this study is to compare the safety and efficacy of intravitreal Eylea injections at a set interval, versus a variable dosing schedule (likely longer than one month), based on a specific individual's disease progression. There will be approximately 50 men and women at least 18 years of age, diagnosed with type 1 or type 2 diabetes, taking part in this study at 5 locations in the United States.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
California Retina Consultants - Bakersfield
Bakersfield, California, United States
California Retina Consultants - Santa Barbara Office
Santa Barbara, California, United States
BCVA Change
Change in mean BCVA from baseline to week 52
Time frame: Week 0 to Week 52
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.